Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Queensland Health
Teva
Colorcon
Merck
Argus Health
McKesson
Cipla

Generated: October 20, 2018

DrugPatentWatch Database Preview

Technetium tc-99m tilmanocept - Generic Drug Details

« Back to Dashboard

What are the generic sources for technetium tc-99m tilmanocept and what is the scope of technetium tc-99m tilmanocept freedom to operate?

Technetium tc-99m tilmanocept is the generic ingredient in one branded drug marketed by Cardinal Health 414 and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m tilmanocept. Two suppliers are listed for this compound.

Summary for technetium tc-99m tilmanocept
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 4
Suppliers / Packagers: 2
Clinical Trials: 4
DailyMed Link:technetium tc-99m tilmanocept at DailyMed

US Patents and Regulatory Information for technetium tc-99m tilmanocept

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cardinal Health 414 LYMPHOSEEK KIT technetium tc-99m tilmanocept INJECTABLE;INJECTION 202207-001 Mar 13, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for technetium tc-99m tilmanocept

Country Document Number Estimated Expiration
Australia 2010208624 ➤ Try a Free Trial
Spain 2228536 ➤ Try a Free Trial
Japan 4056701 ➤ Try a Free Trial
Austria 277642 ➤ Try a Free Trial
Japan 2007332380 ➤ Try a Free Trial
China 102301429 ➤ Try a Free Trial
South Korea 20170027874 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for technetium tc-99m tilmanocept

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90025-1 Sweden ➤ Try a Free Trial PRODUCT NAME: TILMANOCEPT; REG. NO/DATE: EU/1/14/955 20141120
0736 Netherlands ➤ Try a Free Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
C0033 France ➤ Try a Free Trial PRODUCT NAME: TILMANOCEPT; REGISTRATION NO/DATE: EU/1/14/955 20141121
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Queensland Health
Teva
Colorcon
Merck
Argus Health
McKesson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.